Correction: Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential.
- DOI
- 10.1371/journal.pone.0359020
- Published
- 2026
- Container
- PloS one
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pone.0359020,
title = {Correction: Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential.},
author = {Chakraborty A and Diwan A and Chiniga V and Arora V and Thakur Y and Tatake J and Pandey R and Holkar P and Holkar N},
year = {2026},
journal = {PloS one},
doi = {10.1371/journal.pone.0359020},
url = {https://doi.org/10.1371/journal.pone.0359020}
}RIS
TY - JOUR TI - Correction: Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential. AU - Chakraborty A AU - Diwan A AU - Chiniga V AU - Arora V AU - Thakur Y AU - Tatake J AU - Pandey R AU - Holkar P AU - Holkar N PY - 2026 JO - PloS one DO - 10.1371/journal.pone.0359020 UR - https://doi.org/10.1371/journal.pone.0359020 ER -
APA
A, C., A, D., V, C., V, A., Y, T., J, T., R, P., P, H., & N, H. (2026). Correction: Remdesivir-bisPropionate, a better derivative of remdesivir against SARS-CoV-2: Comparison of in vitro and in vivo PK/PD Study as well as its therapeutic potential.. PloS one. https://doi.org/10.1371/journal.pone.0359020
Source records
- pubmed · retrieved 2026-09-25T01:26:47.054Z